Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Mini-Review Article

GnRH in the Treatment of Hypogonadotropic Hypogonadism

Author(s): Carlo Bettocchi*, Marco Rinaldi and Francesco Sebastiani

Volume 27, Issue 24, 2021

Published on: 25 November, 2020

Page: [2754 - 2756] Pages: 3

DOI: 10.2174/1381612826666201125113319

Price: $65

Abstract

Gonadotropin-releasing hormone (GnRH) is the focus of the scientific debate for the treatment of hypogonadotropic hypogonadism. Sexual maturation and reproductive function depend on the pulsatile secretion of GnRH that are mainly congenital and may or may not be associated with other genetic anomalies or syndromes. Clinical manifestations include a wide range of metabolic, endocrine, and psychologic dysfunctions. The following manuscript focuses on the effects of GnRH therapy on fertility and cognitive abilities, aiming to investigate the current level of evidence for this treatment regimen. Current literature has been reviewed with the aim of highlighting the key findings on these two aspects.

Keywords: GnRH, hypogonadotropic hypogonadism, hypogonadism treatment, fertility, idiopathic hypogonadotropic hypogonadism, Kallmann syndrome, combined pituitary hormone deficiency, cognition.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy